California Rice Commission Approves Cibus Inc.'s Field Research Proposal, Paving Way for First Gene Edited Rice Planting in California

Reuters
05 Jun
California Rice Commission Approves Cibus Inc.'s Field Research Proposal, Paving Way for First Gene Edited Rice Planting in California

SAN DIEGO, CA - Cibus Inc., a prominent agricultural biotechnology company, has achieved a significant regulatory milestone with the California Rice Commission's Rice Certification Committee approving its field research proposal on February 26, 2025. This marks the first authorization for planting gene-edited Rice in California. Additionally, in April 2025, the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA-APHIS) designated two of Cibus' Canola traits as not regulated under USDA biotechnology regulations. These developments underscore Cibus' progress in advancing its proprietary gene editing technologies in the agricultural sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cibus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-134948), on June 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10